Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study

W. Ageno; Erica De Candia; L. Iacoviello; Castelnuovo A. Di

doi:10.1016/j.thromres.2021.05.006

Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study

W. Ageno^*
, Erica De Candia
, L. Iacoviello
, Castelnuovo A. Di

^*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

N/A

Lingua originale	Inglese
pagine (da-a)	138-141
Numero di pagine	4
Rivista	Thrombosis Research
Volume	2021/203
Numero di pubblicazione	203
DOI	https://doi.org/10.1016/j.thromres.2021.05.006
Stato di pubblicazione	Pubblicato - 2021

All Science Journal Classification (ASJC) codes

Ematologia

Keywords

Anticoagulants
Atrial Fibrillation
COVID-19
Humans
Propensity Score
SARS-CoV-2
Stroke

Accesso al documento

10.1016/j.thromres.2021.05.006

Altri file e collegamenti

Cita questo

@article{2027415014e54952ab4c3feaa53cb163,

title = "Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study",

abstract = "N/A",

keywords = "Anticoagulants, Atrial Fibrillation, COVID-19, Humans, Propensity Score, SARS-CoV-2, Stroke, Anticoagulants, Atrial Fibrillation, COVID-19, Humans, Propensity Score, SARS-CoV-2, Stroke",

author = "W. Ageno and \{De Candia\}, Erica and L. Iacoviello and Di, \{Castelnuovo A.\}",

year = "2021",

doi = "10.1016/j.thromres.2021.05.006",

language = "English",

volume = "2021/203",

pages = "138--141",

journal = "Thrombosis Research",

issn = "0049-3848",

publisher = "Elsevier Ltd",

number = "203",

}

TY - JOUR

T1 - Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study

AU - Ageno, W.

AU - De Candia, Erica

AU - Iacoviello, L.

AU - Di, Castelnuovo A.

PY - 2021

Y1 - 2021

N2 - N/A

AB - N/A

KW - Anticoagulants

KW - Atrial Fibrillation

KW - COVID-19

KW - Humans

KW - Propensity Score

KW - SARS-CoV-2

KW - Stroke

KW - Anticoagulants

KW - Atrial Fibrillation

KW - COVID-19

KW - Humans

KW - Propensity Score

KW - SARS-CoV-2

KW - Stroke

UR - https://publicatt.unicatt.it/handle/10807/183222

UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85106209287&origin=inward

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106209287&origin=inward

U2 - 10.1016/j.thromres.2021.05.006

DO - 10.1016/j.thromres.2021.05.006

M3 - Article

SN - 0049-3848

VL - 2021/203

SP - 138

EP - 141

JO - Thrombosis Research

JF - Thrombosis Research

IS - 203

ER -

Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study

Abstract

All Science Journal Classification (ASJC) codes

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo